- Home
- DXLG vs BTMD Comparison
DXLG vs BTMD Comparison
Compare DXLG & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXLG
- BTMD
- Stock Information
- Founded
- DXLG 1976
- BTMD 2012
- Country
- DXLG United States
- BTMD United States
- Employees
- DXLG N/A
- BTMD N/A
- Industry
- DXLG Clothing/Shoe/Accessory Stores
- BTMD Medicinal Chemicals and Botanical Products
- Sector
- DXLG Consumer Discretionary
- BTMD Health Care
- Exchange
- DXLG Nasdaq
- BTMD Nasdaq
- Market Cap
- DXLG 128.2M
- BTMD 104.2M
- IPO Year
- DXLG 1987
- BTMD N/A
- Fundamental
- Price
- DXLG $1.01
- BTMD $4.00
- Analyst Decision
- DXLG Buy
- BTMD Strong Buy
- Analyst Count
- DXLG 2
- BTMD 1
- Target Price
- DXLG $2.75
- BTMD $8.00
- AVG Volume (30 Days)
- DXLG 295.8K
- BTMD 181.8K
- Earning Date
- DXLG 05-29-2025
- BTMD 05-07-2025
- Dividend Yield
- DXLG N/A
- BTMD N/A
- EPS Growth
- DXLG N/A
- BTMD 123.33
- EPS
- DXLG 0.05
- BTMD 0.60
- Revenue
- DXLG $467,015,000.00
- BTMD $199,379,000.00
- Revenue This Year
- DXLG N/A
- BTMD $6.20
- Revenue Next Year
- DXLG $3.44
- BTMD $9.24
- P/E Ratio
- DXLG $20.00
- BTMD $6.23
- Revenue Growth
- DXLG N/A
- BTMD 6.44
- 52 Week Low
- DXLG $0.90
- BTMD $3.04
- 52 Week High
- DXLG $3.93
- BTMD $8.44
- Technical
- Relative Strength Index (RSI)
- DXLG 39.58
- BTMD 61.89
- Support Level
- DXLG $0.93
- BTMD $3.15
- Resistance Level
- DXLG $1.20
- BTMD $3.52
- Average True Range (ATR)
- DXLG 0.09
- BTMD 0.22
- MACD
- DXLG 0.04
- BTMD 0.07
- Stochastic Oscillator
- DXLG 35.00
- BTMD 85.37
About DXLG Destination XL Group Inc.
Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.